Article info
Short report
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis
- Correspondence to: Dr Dean M Wingerchuk Mayo Clinic, Scottsdale, Arizona, USA; wingerchuk.deanmayo.edu
Citation
A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing–remitting multiple sclerosis
Publication history
- Received October 17, 2004
- Accepted January 4, 2005
- Revised November 29, 2004
- First published August 16, 2005.
Online issue publication
August 16, 2005
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 Journal of Neurology Neurosurgery and Psychiatry